1. Home
  2. MCBS vs ASMB Comparison

MCBS vs ASMB Comparison

Compare MCBS & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MetroCity Bankshares Inc.

MCBS

MetroCity Bankshares Inc.

HOLD

Current Price

$28.36

Market Cap

679.1M

Sector

Finance

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$36.12

Market Cap

553.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCBS
ASMB
Founded
2006
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
679.1M
553.6M
IPO Year
2019
2010

Fundamental Metrics

Financial Performance
Metric
MCBS
ASMB
Price
$28.36
$36.12
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$31.00
$43.40
AVG Volume (30 Days)
51.9K
124.4K
Earning Date
01-20-2026
11-10-2025
Dividend Yield
3.52%
N/A
EPS Growth
11.15
N/A
EPS
2.59
N/A
Revenue
$147,349,000.00
$37,191,000.00
Revenue This Year
$13.89
$42.01
Revenue Next Year
$33.10
N/A
P/E Ratio
$10.96
N/A
Revenue Growth
8.69
31.30
52 Week Low
$24.24
$7.75
52 Week High
$35.45
$39.71

Technical Indicators

Market Signals
Indicator
MCBS
ASMB
Relative Strength Index (RSI) 71.29 57.82
Support Level $27.04 $35.05
Resistance Level $27.48 $38.82
Average True Range (ATR) 0.60 1.91
MACD 0.26 -0.32
Stochastic Oscillator 98.38 42.70

Price Performance

Historical Comparison
MCBS
ASMB

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: